🌏 Phase 8 · v3.0 · ASEAN Regional Expansion · 1 Jul - 3 Nov 2029 · 18 Weeks · 6 Sprints
← Hub ← Phase 7 Phase 9 → 🌏 Phase 8 v3.0 ASEAN

Phase 8 · v3.0 · ASEAN Regional Expansion

From Malaysia platform to ASEAN regional standard. Indonesia · Thailand · Vietnam pilots. Localisation deepening · cross-border M8 International · ASEAN regulator harmonisation. By Q4-end 2029: 300+ tenants across 4 countries · MediEco becomes regional healthcare OS.

1. 🎯 Phase Summary

PhasePhase 8 · v3.0 · ASEAN Regional Expansion
Duration1 Jul - 3 Nov 2029 (18 weeks · 6 sprints × 3 weeks)
Goal3 country pilots (ID/TH/VN) · localisation depth · M8 Intl cross-border · regional regulator harmonisation · scale 100 → 300+ tenants across 4 countries

2. 🎨 Themes

  • Regional pilot, not just Malaysia — Indonesia (Jakarta+Surabaya) · Thailand (Bangkok+Chiang Mai) · Vietnam (HCMC+Hanoi) — 3 country pilots with local partners. ASEAN is no longer abstract — it is 6 cities live.
  • Localisation deepening — Beyond translation. Per-country regulatory adapters (BPJS Indonesia · NHSO Thailand · Vietnam Social Security) · local payment rails · local medical conventions · local AI prompt tuning.
  • Cross-border patient continuity — M8 International — Malaysian going to Thailand for medical tourism keeps records continuous. Indonesian working in KL bridges insurance back home. Borders dissolve clinically.
  • Regional regulator harmonisation — Doc Zam-led ASEAN clinical advisory · WHO ASEAN office engagement · ISO-aligned governance · MOH MOUs between Malaysia and pilot countries.
  • Platform sovereignty — Each country tenancy is data-sovereign by default. Cross-border explicit opt-in only. PDPA Malaysia · UU PDP Indonesia · PDPA Thailand · Decree 13 Vietnam — all enforced.

3. 🏃 Sprint Catalog

5. 📊 Success Metrics

300+
Tenants live across 4 countries
4
Countries (MY · ID · TH · VN)
22+
Cities with active clinics
4
Languages (BM · ID · TH · VI)
1
Regional regulator MOU (ASEAN)
15
Total modules (M1-M16 deployed)

6. 🚪 Phase Exit Criteria

  • 6 cities live across 3 pilot countries · ≥ 200 tenants outside Malaysia
  • BPJS · NHSO · VSS adapters all certified by respective regulators
  • M8 International cross-border bridge stable · ≥ 50 patients with cross-border records
  • Per-country PDPA equivalents verified · data-sovereignty defaults active
  • Doc Zam ASEAN clinical advisory board chartered (≥ 3 country advisors)
  • v3.0 production cert public · ASEAN regional press coverage
  • 300+ total tenants confirmed live and stable for 14+ days

7. 🔮 Beyond This Phase

v3.5 (Phase 9) shifts focus from geographical to specialty depth. Mental health · dermatology · endocrinology · orthopaedics · oncology — 5 specialty modules. Target Q2 2030: 500+ tenants with deeper clinical surface area.